References

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J

Mol Biol 215(3):403–410

Amberger JS, Bocchini CA, Scott AF, Hamosh A (2019) OMIM.org: leveraging knowledge across

phenotype–gene relationships. Nucleic Acids Res 47(D1):D1038–D1043

Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M et al (2014) The ChEMBL

bioactivity database: an update. Nucleic Acids Res 42(D1):D1083–D1090

Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C

(1996a) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for

the treatment of penile erectile dysfunction. Int J Impot Res 8(2):47–52

Boolell M, Gepi-Attee S, Gingell JC, Allen MJ (1996b) Sildenafil, a novel effective oral therapy for

male erectile dysfunction. Br J Urol 78(2):257–261

Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M et al (2007) The BioGRID

interaction database: 2008 update. Nucleic Acids Res 36(suppl 1):D637–D640

Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-

effect similarity. Science 321(5886):263–266

Chatr-Aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, Cesareni G

(2007) MINT: the molecular INTeraction database. Nucleic Acids Res 35(suppl_1):D572–

D574

Chen X, Ji ZL, Chen YZ (2002) TTD: therapeutic target database. Nucleic Acids Res 30(1):

412–415

Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, Barabási AL, Loscalzo J (2018) Network-

based approach to prediction and population-based validation of in silico drug repurposing. Nat

Commun 9(1):1–12

Cheng J, Yang L, Kumar V, Agarwal P (2014) Systematic evaluation of connectivity map for

disease indications. Genome Med 6(12):95

Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G et al (2014) The Reactome pathway

knowledgebase. Nucleic Acids Res 42(D1):D472–D477

Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP et al (2011) Computational

repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med

3(96):96ra76-96ra76

Fliri AF, Loging WT, Thadeio PF, Volkmann RA (2005) Analysis of drug-induced effect patterns

to link structure and side effects of medicines. Nat Chem Biol 1(7):389–397

Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in

the treatment of erectile dysfunction. N Engl J Med 338(20):1397–1404

Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, Miller CA (2013)

DGIdb: mining the druggable genome. Nat Methods 10(12):1209–1210

Hasnain SE, Ehtesham NZ, Tripathi D, Grover S, Kumar A, Alam A, Pandey S, inventors; Indian

institute of Technology Delhi, assignee (2020) A medicament for the treatment of diseases by

biofilm forming microorganisms. United States patent application US 16/607,061

Hert J, Keiser MJ, Irwin JJ, Oprea TI, Shoichet BK (2008) Quantifying the relationships among

drug classes. J Chem Inf Model 48(4):755–765

Hewett M, Oliver DE, Rubin DL, Easton KL, Stuart JM, Altman RB, Klein TE (2002) PharmGKB:

the pharmacogenetics knowledge base. Nucleic Acids Res 30(1):163–165

Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res

28(1):27–30

Karp PD, Ouzounis CA, Moore-Kochlacs C, Goldovsky L, Kaipa P, Ahrén D, López-Bigas N

(2005) Expansion of the BioCyc collection of pathway/genome databases to 160 genomes.

Nucleic Acids Res 33(19):6083–6089

Keenan AB, Jenkins SL, Jagodnik KM, Koplev S, He E, Torre D et al (2018) The library of

integrated network-based cellular signatures NIH program: system-level cataloging of human

cells response to perturbations. Cell Syst 6(1):13–24

46

S. Yellaboina and S. E. Hasnain